Global T-Cell Therapy Market Growth (Status and Outlook) 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
LPI (LP Information)' newest research report, the “T-Cell Therapy Industry Forecast” looks at past sales and reviews total world T-Cell Therapy sales in 2022, providing a comprehensive analysis by region and market sector of projected T-Cell Therapy sales for 2023 through 2029. With T-Cell Therapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world T-Cell Therapy industry.
This Insight Report provides a comprehensive analysis of the global T-Cell Therapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on T-Cell Therapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global T-Cell Therapy market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for T-Cell Therapy and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global T-Cell Therapy.
The global T-Cell Therapy market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for T-Cell Therapy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for T-Cell Therapy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for T-Cell Therapy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key T-Cell Therapy players cover Gilead Sciences, Inc., Sorrento Therapeutics, Fate Therapeutics Inc., Novartis International AG, AbbVie Inc., Adaptimmune Therapeutics PLC, Bluebird Bio, TCR2 Therapeutics, Inc. and Pfizer Inc., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of T-Cell Therapy market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
LPI (LP Information)' newest research report, the “T-Cell Therapy Industry Forecast” looks at past sales and reviews total world T-Cell Therapy sales in 2022, providing a comprehensive analysis by region and market sector of projected T-Cell Therapy sales for 2023 through 2029. With T-Cell Therapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world T-Cell Therapy industry.
This Insight Report provides a comprehensive analysis of the global T-Cell Therapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on T-Cell Therapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global T-Cell Therapy market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for T-Cell Therapy and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global T-Cell Therapy.
The global T-Cell Therapy market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for T-Cell Therapy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for T-Cell Therapy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for T-Cell Therapy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key T-Cell Therapy players cover Gilead Sciences, Inc., Sorrento Therapeutics, Fate Therapeutics Inc., Novartis International AG, AbbVie Inc., Adaptimmune Therapeutics PLC, Bluebird Bio, TCR2 Therapeutics, Inc. and Pfizer Inc., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of T-Cell Therapy market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
- CAR T Cell Therapy
- TCR Therapy
- TIL Therapy
- Hospitals
- Clinics & Ambulatory Centers
- Cancer Research Institutes
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Gilead Sciences, Inc.
- Sorrento Therapeutics
- Fate Therapeutics Inc.
- Novartis International AG
- AbbVie Inc.
- Adaptimmune Therapeutics PLC
- Bluebird Bio
- TCR2 Therapeutics, Inc.
- Pfizer Inc.
- DiaCarta, Inc.
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global T-Cell Therapy Market Size 2018-2029
2.1.2 T-Cell Therapy Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 T-Cell Therapy Segment by Type
2.2.1 CAR T Cell Therapy
2.2.2 TCR Therapy
2.2.3 TIL Therapy
2.3 T-Cell Therapy Market Size by Type
2.3.1 T-Cell Therapy Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global T-Cell Therapy Market Size Market Share by Type (2018-2023)
2.4 T-Cell Therapy Segment by Application
2.4.1 Hospitals
2.4.2 Clinics & Ambulatory Centers
2.4.3 Cancer Research Institutes
2.4.4 Others
2.5 T-Cell Therapy Market Size by Application
2.5.1 T-Cell Therapy Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global T-Cell Therapy Market Size Market Share by Application (2018-2023)
3 T-CELL THERAPY MARKET SIZE BY PLAYER
3.1 T-Cell Therapy Market Size Market Share by Players
3.1.1 Global T-Cell Therapy Revenue by Players (2018-2023)
3.1.2 Global T-Cell Therapy Revenue Market Share by Players (2018-2023)
3.2 Global T-Cell Therapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 T-CELL THERAPY BY REGIONS
4.1 T-Cell Therapy Market Size by Regions (2018-2023)
4.2 Americas T-Cell Therapy Market Size Growth (2018-2023)
4.3 APAC T-Cell Therapy Market Size Growth (2018-2023)
4.4 Europe T-Cell Therapy Market Size Growth (2018-2023)
4.5 Middle East & Africa T-Cell Therapy Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas T-Cell Therapy Market Size by Country (2018-2023)
5.2 Americas T-Cell Therapy Market Size by Type (2018-2023)
5.3 Americas T-Cell Therapy Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC T-Cell Therapy Market Size by Region (2018-2023)
6.2 APAC T-Cell Therapy Market Size by Type (2018-2023)
6.3 APAC T-Cell Therapy Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe T-Cell Therapy by Country (2018-2023)
7.2 Europe T-Cell Therapy Market Size by Type (2018-2023)
7.3 Europe T-Cell Therapy Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa T-Cell Therapy by Region (2018-2023)
8.2 Middle East & Africa T-Cell Therapy Market Size by Type (2018-2023)
8.3 Middle East & Africa T-Cell Therapy Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL T-CELL THERAPY MARKET FORECAST
10.1 Global T-Cell Therapy Forecast by Regions (2024-2029)
10.1.1 Global T-Cell Therapy Forecast by Regions (2024-2029)
10.1.2 Americas T-Cell Therapy Forecast
10.1.3 APAC T-Cell Therapy Forecast
10.1.4 Europe T-Cell Therapy Forecast
10.1.5 Middle East & Africa T-Cell Therapy Forecast
10.2 Americas T-Cell Therapy Forecast by Country (2024-2029)
10.2.1 United States T-Cell Therapy Market Forecast
10.2.2 Canada T-Cell Therapy Market Forecast
10.2.3 Mexico T-Cell Therapy Market Forecast
10.2.4 Brazil T-Cell Therapy Market Forecast
10.3 APAC T-Cell Therapy Forecast by Region (2024-2029)
10.3.1 China T-Cell Therapy Market Forecast
10.3.2 Japan T-Cell Therapy Market Forecast
10.3.3 Korea T-Cell Therapy Market Forecast
10.3.4 Southeast Asia T-Cell Therapy Market Forecast
10.3.5 India T-Cell Therapy Market Forecast
10.3.6 Australia T-Cell Therapy Market Forecast
10.4 Europe T-Cell Therapy Forecast by Country (2024-2029)
10.4.1 Germany T-Cell Therapy Market Forecast
10.4.2 France T-Cell Therapy Market Forecast
10.4.3 UK T-Cell Therapy Market Forecast
10.4.4 Italy T-Cell Therapy Market Forecast
10.4.5 Russia T-Cell Therapy Market Forecast
10.5 Middle East & Africa T-Cell Therapy Forecast by Region (2024-2029)
10.5.1 Egypt T-Cell Therapy Market Forecast
10.5.2 South Africa T-Cell Therapy Market Forecast
10.5.3 Israel T-Cell Therapy Market Forecast
10.5.4 Turkey T-Cell Therapy Market Forecast
10.5.5 GCC Countries T-Cell Therapy Market Forecast
10.6 Global T-Cell Therapy Forecast by Type (2024-2029)
10.7 Global T-Cell Therapy Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Gilead Sciences, Inc.
11.1.1 Gilead Sciences, Inc. Company Information
11.1.2 Gilead Sciences, Inc. T-Cell Therapy Product Offered
11.1.3 Gilead Sciences, Inc. T-Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Gilead Sciences, Inc. Main Business Overview
11.1.5 Gilead Sciences, Inc. Latest Developments
11.2 Sorrento Therapeutics
11.2.1 Sorrento Therapeutics Company Information
11.2.2 Sorrento Therapeutics T-Cell Therapy Product Offered
11.2.3 Sorrento Therapeutics T-Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Sorrento Therapeutics Main Business Overview
11.2.5 Sorrento Therapeutics Latest Developments
11.3 Fate Therapeutics Inc.
11.3.1 Fate Therapeutics Inc. Company Information
11.3.2 Fate Therapeutics Inc. T-Cell Therapy Product Offered
11.3.3 Fate Therapeutics Inc. T-Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Fate Therapeutics Inc. Main Business Overview
11.3.5 Fate Therapeutics Inc. Latest Developments
11.4 Novartis International AG
11.4.1 Novartis International AG Company Information
11.4.2 Novartis International AG T-Cell Therapy Product Offered
11.4.3 Novartis International AG T-Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Novartis International AG Main Business Overview
11.4.5 Novartis International AG Latest Developments
11.5 AbbVie Inc.
11.5.1 AbbVie Inc. Company Information
11.5.2 AbbVie Inc. T-Cell Therapy Product Offered
11.5.3 AbbVie Inc. T-Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 AbbVie Inc. Main Business Overview
11.5.5 AbbVie Inc. Latest Developments
11.6 Adaptimmune Therapeutics PLC
11.6.1 Adaptimmune Therapeutics PLC Company Information
11.6.2 Adaptimmune Therapeutics PLC T-Cell Therapy Product Offered
11.6.3 Adaptimmune Therapeutics PLC T-Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Adaptimmune Therapeutics PLC Main Business Overview
11.6.5 Adaptimmune Therapeutics PLC Latest Developments
11.7 Bluebird Bio
11.7.1 Bluebird Bio Company Information
11.7.2 Bluebird Bio T-Cell Therapy Product Offered
11.7.3 Bluebird Bio T-Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Bluebird Bio Main Business Overview
11.7.5 Bluebird Bio Latest Developments
11.8 TCR2 Therapeutics, Inc.
11.8.1 TCR2 Therapeutics, Inc. Company Information
11.8.2 TCR2 Therapeutics, Inc. T-Cell Therapy Product Offered
11.8.3 TCR2 Therapeutics, Inc. T-Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 TCR2 Therapeutics, Inc. Main Business Overview
11.8.5 TCR2 Therapeutics, Inc. Latest Developments
11.9 Pfizer Inc.
11.9.1 Pfizer Inc. Company Information
11.9.2 Pfizer Inc. T-Cell Therapy Product Offered
11.9.3 Pfizer Inc. T-Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Pfizer Inc. Main Business Overview
11.9.5 Pfizer Inc. Latest Developments
11.10 DiaCarta, Inc.
11.10.1 DiaCarta, Inc. Company Information
11.10.2 DiaCarta, Inc. T-Cell Therapy Product Offered
11.10.3 DiaCarta, Inc. T-Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 DiaCarta, Inc. Main Business Overview
11.10.5 DiaCarta, Inc. Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global T-Cell Therapy Market Size 2018-2029
2.1.2 T-Cell Therapy Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 T-Cell Therapy Segment by Type
2.2.1 CAR T Cell Therapy
2.2.2 TCR Therapy
2.2.3 TIL Therapy
2.3 T-Cell Therapy Market Size by Type
2.3.1 T-Cell Therapy Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global T-Cell Therapy Market Size Market Share by Type (2018-2023)
2.4 T-Cell Therapy Segment by Application
2.4.1 Hospitals
2.4.2 Clinics & Ambulatory Centers
2.4.3 Cancer Research Institutes
2.4.4 Others
2.5 T-Cell Therapy Market Size by Application
2.5.1 T-Cell Therapy Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global T-Cell Therapy Market Size Market Share by Application (2018-2023)
3 T-CELL THERAPY MARKET SIZE BY PLAYER
3.1 T-Cell Therapy Market Size Market Share by Players
3.1.1 Global T-Cell Therapy Revenue by Players (2018-2023)
3.1.2 Global T-Cell Therapy Revenue Market Share by Players (2018-2023)
3.2 Global T-Cell Therapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 T-CELL THERAPY BY REGIONS
4.1 T-Cell Therapy Market Size by Regions (2018-2023)
4.2 Americas T-Cell Therapy Market Size Growth (2018-2023)
4.3 APAC T-Cell Therapy Market Size Growth (2018-2023)
4.4 Europe T-Cell Therapy Market Size Growth (2018-2023)
4.5 Middle East & Africa T-Cell Therapy Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas T-Cell Therapy Market Size by Country (2018-2023)
5.2 Americas T-Cell Therapy Market Size by Type (2018-2023)
5.3 Americas T-Cell Therapy Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC T-Cell Therapy Market Size by Region (2018-2023)
6.2 APAC T-Cell Therapy Market Size by Type (2018-2023)
6.3 APAC T-Cell Therapy Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe T-Cell Therapy by Country (2018-2023)
7.2 Europe T-Cell Therapy Market Size by Type (2018-2023)
7.3 Europe T-Cell Therapy Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa T-Cell Therapy by Region (2018-2023)
8.2 Middle East & Africa T-Cell Therapy Market Size by Type (2018-2023)
8.3 Middle East & Africa T-Cell Therapy Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL T-CELL THERAPY MARKET FORECAST
10.1 Global T-Cell Therapy Forecast by Regions (2024-2029)
10.1.1 Global T-Cell Therapy Forecast by Regions (2024-2029)
10.1.2 Americas T-Cell Therapy Forecast
10.1.3 APAC T-Cell Therapy Forecast
10.1.4 Europe T-Cell Therapy Forecast
10.1.5 Middle East & Africa T-Cell Therapy Forecast
10.2 Americas T-Cell Therapy Forecast by Country (2024-2029)
10.2.1 United States T-Cell Therapy Market Forecast
10.2.2 Canada T-Cell Therapy Market Forecast
10.2.3 Mexico T-Cell Therapy Market Forecast
10.2.4 Brazil T-Cell Therapy Market Forecast
10.3 APAC T-Cell Therapy Forecast by Region (2024-2029)
10.3.1 China T-Cell Therapy Market Forecast
10.3.2 Japan T-Cell Therapy Market Forecast
10.3.3 Korea T-Cell Therapy Market Forecast
10.3.4 Southeast Asia T-Cell Therapy Market Forecast
10.3.5 India T-Cell Therapy Market Forecast
10.3.6 Australia T-Cell Therapy Market Forecast
10.4 Europe T-Cell Therapy Forecast by Country (2024-2029)
10.4.1 Germany T-Cell Therapy Market Forecast
10.4.2 France T-Cell Therapy Market Forecast
10.4.3 UK T-Cell Therapy Market Forecast
10.4.4 Italy T-Cell Therapy Market Forecast
10.4.5 Russia T-Cell Therapy Market Forecast
10.5 Middle East & Africa T-Cell Therapy Forecast by Region (2024-2029)
10.5.1 Egypt T-Cell Therapy Market Forecast
10.5.2 South Africa T-Cell Therapy Market Forecast
10.5.3 Israel T-Cell Therapy Market Forecast
10.5.4 Turkey T-Cell Therapy Market Forecast
10.5.5 GCC Countries T-Cell Therapy Market Forecast
10.6 Global T-Cell Therapy Forecast by Type (2024-2029)
10.7 Global T-Cell Therapy Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Gilead Sciences, Inc.
11.1.1 Gilead Sciences, Inc. Company Information
11.1.2 Gilead Sciences, Inc. T-Cell Therapy Product Offered
11.1.3 Gilead Sciences, Inc. T-Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Gilead Sciences, Inc. Main Business Overview
11.1.5 Gilead Sciences, Inc. Latest Developments
11.2 Sorrento Therapeutics
11.2.1 Sorrento Therapeutics Company Information
11.2.2 Sorrento Therapeutics T-Cell Therapy Product Offered
11.2.3 Sorrento Therapeutics T-Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Sorrento Therapeutics Main Business Overview
11.2.5 Sorrento Therapeutics Latest Developments
11.3 Fate Therapeutics Inc.
11.3.1 Fate Therapeutics Inc. Company Information
11.3.2 Fate Therapeutics Inc. T-Cell Therapy Product Offered
11.3.3 Fate Therapeutics Inc. T-Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Fate Therapeutics Inc. Main Business Overview
11.3.5 Fate Therapeutics Inc. Latest Developments
11.4 Novartis International AG
11.4.1 Novartis International AG Company Information
11.4.2 Novartis International AG T-Cell Therapy Product Offered
11.4.3 Novartis International AG T-Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Novartis International AG Main Business Overview
11.4.5 Novartis International AG Latest Developments
11.5 AbbVie Inc.
11.5.1 AbbVie Inc. Company Information
11.5.2 AbbVie Inc. T-Cell Therapy Product Offered
11.5.3 AbbVie Inc. T-Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 AbbVie Inc. Main Business Overview
11.5.5 AbbVie Inc. Latest Developments
11.6 Adaptimmune Therapeutics PLC
11.6.1 Adaptimmune Therapeutics PLC Company Information
11.6.2 Adaptimmune Therapeutics PLC T-Cell Therapy Product Offered
11.6.3 Adaptimmune Therapeutics PLC T-Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Adaptimmune Therapeutics PLC Main Business Overview
11.6.5 Adaptimmune Therapeutics PLC Latest Developments
11.7 Bluebird Bio
11.7.1 Bluebird Bio Company Information
11.7.2 Bluebird Bio T-Cell Therapy Product Offered
11.7.3 Bluebird Bio T-Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Bluebird Bio Main Business Overview
11.7.5 Bluebird Bio Latest Developments
11.8 TCR2 Therapeutics, Inc.
11.8.1 TCR2 Therapeutics, Inc. Company Information
11.8.2 TCR2 Therapeutics, Inc. T-Cell Therapy Product Offered
11.8.3 TCR2 Therapeutics, Inc. T-Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 TCR2 Therapeutics, Inc. Main Business Overview
11.8.5 TCR2 Therapeutics, Inc. Latest Developments
11.9 Pfizer Inc.
11.9.1 Pfizer Inc. Company Information
11.9.2 Pfizer Inc. T-Cell Therapy Product Offered
11.9.3 Pfizer Inc. T-Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Pfizer Inc. Main Business Overview
11.9.5 Pfizer Inc. Latest Developments
11.10 DiaCarta, Inc.
11.10.1 DiaCarta, Inc. Company Information
11.10.2 DiaCarta, Inc. T-Cell Therapy Product Offered
11.10.3 DiaCarta, Inc. T-Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 DiaCarta, Inc. Main Business Overview
11.10.5 DiaCarta, Inc. Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. T-Cell Therapy Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of CAR T Cell Therapy
Table 3. Major Players of TCR Therapy
Table 4. Major Players of TIL Therapy
Table 5. T-Cell Therapy Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 6. Global T-Cell Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 7. Global T-Cell Therapy Market Size Market Share by Type (2018-2023)
Table 8. T-Cell Therapy Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 9. Global T-Cell Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 10. Global T-Cell Therapy Market Size Market Share by Application (2018-2023)
Table 11. Global T-Cell Therapy Revenue by Players (2018-2023) & ($ Millions)
Table 12. Global T-Cell Therapy Revenue Market Share by Player (2018-2023)
Table 13. T-Cell Therapy Key Players Head office and Products Offered
Table 14. T-Cell Therapy Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global T-Cell Therapy Market Size by Regions 2018-2023 & ($ Millions)
Table 18. Global T-Cell Therapy Market Size Market Share by Regions (2018-2023)
Table 19. Global T-Cell Therapy Revenue by Country/Region (2018-2023) & ($ millions)
Table 20. Global T-Cell Therapy Revenue Market Share by Country/Region (2018-2023)
Table 21. Americas T-Cell Therapy Market Size by Country (2018-2023) & ($ Millions)
Table 22. Americas T-Cell Therapy Market Size Market Share by Country (2018-2023)
Table 23. Americas T-Cell Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 24. Americas T-Cell Therapy Market Size Market Share by Type (2018-2023)
Table 25. Americas T-Cell Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 26. Americas T-Cell Therapy Market Size Market Share by Application (2018-2023)
Table 27. APAC T-Cell Therapy Market Size by Region (2018-2023) & ($ Millions)
Table 28. APAC T-Cell Therapy Market Size Market Share by Region (2018-2023)
Table 29. APAC T-Cell Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 30. APAC T-Cell Therapy Market Size Market Share by Type (2018-2023)
Table 31. APAC T-Cell Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 32. APAC T-Cell Therapy Market Size Market Share by Application (2018-2023)
Table 33. Europe T-Cell Therapy Market Size by Country (2018-2023) & ($ Millions)
Table 34. Europe T-Cell Therapy Market Size Market Share by Country (2018-2023)
Table 35. Europe T-Cell Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 36. Europe T-Cell Therapy Market Size Market Share by Type (2018-2023)
Table 37. Europe T-Cell Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 38. Europe T-Cell Therapy Market Size Market Share by Application (2018-2023)
Table 39. Middle East & Africa T-Cell Therapy Market Size by Region (2018-2023) & ($ Millions)
Table 40. Middle East & Africa T-Cell Therapy Market Size Market Share by Region (2018-2023)
Table 41. Middle East & Africa T-Cell Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 42. Middle East & Africa T-Cell Therapy Market Size Market Share by Type (2018-2023)
Table 43. Middle East & Africa T-Cell Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 44. Middle East & Africa T-Cell Therapy Market Size Market Share by Application (2018-2023)
Table 45. Key Market Drivers & Growth Opportunities of T-Cell Therapy
Table 46. Key Market Challenges & Risks of T-Cell Therapy
Table 47. Key Industry Trends of T-Cell Therapy
Table 48. Global T-Cell Therapy Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 49. Global T-Cell Therapy Market Size Market Share Forecast by Regions (2024-2029)
Table 50. Global T-Cell Therapy Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 51. Global T-Cell Therapy Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 52. Gilead Sciences, Inc. Details, Company Type, T-Cell Therapy Area Served and Its Competitors
Table 53. Gilead Sciences, Inc. T-Cell Therapy Product Offered
Table 54. Gilead Sciences, Inc. T-Cell Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 55. Gilead Sciences, Inc. Main Business
Table 56. Gilead Sciences, Inc. Latest Developments
Table 57. Sorrento Therapeutics Details, Company Type, T-Cell Therapy Area Served and Its Competitors
Table 58. Sorrento Therapeutics T-Cell Therapy Product Offered
Table 59. Sorrento Therapeutics Main Business
Table 60. Sorrento Therapeutics T-Cell Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 61. Sorrento Therapeutics Latest Developments
Table 62. Fate Therapeutics Inc. Details, Company Type, T-Cell Therapy Area Served and Its Competitors
Table 63. Fate Therapeutics Inc. T-Cell Therapy Product Offered
Table 64. Fate Therapeutics Inc. Main Business
Table 65. Fate Therapeutics Inc. T-Cell Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 66. Fate Therapeutics Inc. Latest Developments
Table 67. Novartis International AG Details, Company Type, T-Cell Therapy Area Served and Its Competitors
Table 68. Novartis International AG T-Cell Therapy Product Offered
Table 69. Novartis International AG Main Business
Table 70. Novartis International AG T-Cell Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 71. Novartis International AG Latest Developments
Table 72. AbbVie Inc. Details, Company Type, T-Cell Therapy Area Served and Its Competitors
Table 73. AbbVie Inc. T-Cell Therapy Product Offered
Table 74. AbbVie Inc. Main Business
Table 75. AbbVie Inc. T-Cell Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 76. AbbVie Inc. Latest Developments
Table 77. Adaptimmune Therapeutics PLC Details, Company Type, T-Cell Therapy Area Served and Its Competitors
Table 78. Adaptimmune Therapeutics PLC T-Cell Therapy Product Offered
Table 79. Adaptimmune Therapeutics PLC Main Business
Table 80. Adaptimmune Therapeutics PLC T-Cell Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 81. Adaptimmune Therapeutics PLC Latest Developments
Table 82. Bluebird Bio Details, Company Type, T-Cell Therapy Area Served and Its Competitors
Table 83. Bluebird Bio T-Cell Therapy Product Offered
Table 84. Bluebird Bio Main Business
Table 85. Bluebird Bio T-Cell Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 86. Bluebird Bio Latest Developments
Table 87. TCR2 Therapeutics, Inc. Details, Company Type, T-Cell Therapy Area Served and Its Competitors
Table 88. TCR2 Therapeutics, Inc. T-Cell Therapy Product Offered
Table 89. TCR2 Therapeutics, Inc. Main Business
Table 90. TCR2 Therapeutics, Inc. T-Cell Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 91. TCR2 Therapeutics, Inc. Latest Developments
Table 92. Pfizer Inc. Details, Company Type, T-Cell Therapy Area Served and Its Competitors
Table 93. Pfizer Inc. T-Cell Therapy Product Offered
Table 94. Pfizer Inc. Main Business
Table 95. Pfizer Inc. T-Cell Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 96. Pfizer Inc. Latest Developments
Table 97. DiaCarta, Inc. Details, Company Type, T-Cell Therapy Area Served and Its Competitors
Table 98. DiaCarta, Inc. T-Cell Therapy Product Offered
Table 99. DiaCarta, Inc. Main Business
Table 100. DiaCarta, Inc. T-Cell Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 101. DiaCarta, Inc. Latest Developments
Table 1. T-Cell Therapy Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of CAR T Cell Therapy
Table 3. Major Players of TCR Therapy
Table 4. Major Players of TIL Therapy
Table 5. T-Cell Therapy Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 6. Global T-Cell Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 7. Global T-Cell Therapy Market Size Market Share by Type (2018-2023)
Table 8. T-Cell Therapy Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 9. Global T-Cell Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 10. Global T-Cell Therapy Market Size Market Share by Application (2018-2023)
Table 11. Global T-Cell Therapy Revenue by Players (2018-2023) & ($ Millions)
Table 12. Global T-Cell Therapy Revenue Market Share by Player (2018-2023)
Table 13. T-Cell Therapy Key Players Head office and Products Offered
Table 14. T-Cell Therapy Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global T-Cell Therapy Market Size by Regions 2018-2023 & ($ Millions)
Table 18. Global T-Cell Therapy Market Size Market Share by Regions (2018-2023)
Table 19. Global T-Cell Therapy Revenue by Country/Region (2018-2023) & ($ millions)
Table 20. Global T-Cell Therapy Revenue Market Share by Country/Region (2018-2023)
Table 21. Americas T-Cell Therapy Market Size by Country (2018-2023) & ($ Millions)
Table 22. Americas T-Cell Therapy Market Size Market Share by Country (2018-2023)
Table 23. Americas T-Cell Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 24. Americas T-Cell Therapy Market Size Market Share by Type (2018-2023)
Table 25. Americas T-Cell Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 26. Americas T-Cell Therapy Market Size Market Share by Application (2018-2023)
Table 27. APAC T-Cell Therapy Market Size by Region (2018-2023) & ($ Millions)
Table 28. APAC T-Cell Therapy Market Size Market Share by Region (2018-2023)
Table 29. APAC T-Cell Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 30. APAC T-Cell Therapy Market Size Market Share by Type (2018-2023)
Table 31. APAC T-Cell Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 32. APAC T-Cell Therapy Market Size Market Share by Application (2018-2023)
Table 33. Europe T-Cell Therapy Market Size by Country (2018-2023) & ($ Millions)
Table 34. Europe T-Cell Therapy Market Size Market Share by Country (2018-2023)
Table 35. Europe T-Cell Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 36. Europe T-Cell Therapy Market Size Market Share by Type (2018-2023)
Table 37. Europe T-Cell Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 38. Europe T-Cell Therapy Market Size Market Share by Application (2018-2023)
Table 39. Middle East & Africa T-Cell Therapy Market Size by Region (2018-2023) & ($ Millions)
Table 40. Middle East & Africa T-Cell Therapy Market Size Market Share by Region (2018-2023)
Table 41. Middle East & Africa T-Cell Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 42. Middle East & Africa T-Cell Therapy Market Size Market Share by Type (2018-2023)
Table 43. Middle East & Africa T-Cell Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 44. Middle East & Africa T-Cell Therapy Market Size Market Share by Application (2018-2023)
Table 45. Key Market Drivers & Growth Opportunities of T-Cell Therapy
Table 46. Key Market Challenges & Risks of T-Cell Therapy
Table 47. Key Industry Trends of T-Cell Therapy
Table 48. Global T-Cell Therapy Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 49. Global T-Cell Therapy Market Size Market Share Forecast by Regions (2024-2029)
Table 50. Global T-Cell Therapy Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 51. Global T-Cell Therapy Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 52. Gilead Sciences, Inc. Details, Company Type, T-Cell Therapy Area Served and Its Competitors
Table 53. Gilead Sciences, Inc. T-Cell Therapy Product Offered
Table 54. Gilead Sciences, Inc. T-Cell Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 55. Gilead Sciences, Inc. Main Business
Table 56. Gilead Sciences, Inc. Latest Developments
Table 57. Sorrento Therapeutics Details, Company Type, T-Cell Therapy Area Served and Its Competitors
Table 58. Sorrento Therapeutics T-Cell Therapy Product Offered
Table 59. Sorrento Therapeutics Main Business
Table 60. Sorrento Therapeutics T-Cell Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 61. Sorrento Therapeutics Latest Developments
Table 62. Fate Therapeutics Inc. Details, Company Type, T-Cell Therapy Area Served and Its Competitors
Table 63. Fate Therapeutics Inc. T-Cell Therapy Product Offered
Table 64. Fate Therapeutics Inc. Main Business
Table 65. Fate Therapeutics Inc. T-Cell Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 66. Fate Therapeutics Inc. Latest Developments
Table 67. Novartis International AG Details, Company Type, T-Cell Therapy Area Served and Its Competitors
Table 68. Novartis International AG T-Cell Therapy Product Offered
Table 69. Novartis International AG Main Business
Table 70. Novartis International AG T-Cell Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 71. Novartis International AG Latest Developments
Table 72. AbbVie Inc. Details, Company Type, T-Cell Therapy Area Served and Its Competitors
Table 73. AbbVie Inc. T-Cell Therapy Product Offered
Table 74. AbbVie Inc. Main Business
Table 75. AbbVie Inc. T-Cell Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 76. AbbVie Inc. Latest Developments
Table 77. Adaptimmune Therapeutics PLC Details, Company Type, T-Cell Therapy Area Served and Its Competitors
Table 78. Adaptimmune Therapeutics PLC T-Cell Therapy Product Offered
Table 79. Adaptimmune Therapeutics PLC Main Business
Table 80. Adaptimmune Therapeutics PLC T-Cell Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 81. Adaptimmune Therapeutics PLC Latest Developments
Table 82. Bluebird Bio Details, Company Type, T-Cell Therapy Area Served and Its Competitors
Table 83. Bluebird Bio T-Cell Therapy Product Offered
Table 84. Bluebird Bio Main Business
Table 85. Bluebird Bio T-Cell Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 86. Bluebird Bio Latest Developments
Table 87. TCR2 Therapeutics, Inc. Details, Company Type, T-Cell Therapy Area Served and Its Competitors
Table 88. TCR2 Therapeutics, Inc. T-Cell Therapy Product Offered
Table 89. TCR2 Therapeutics, Inc. Main Business
Table 90. TCR2 Therapeutics, Inc. T-Cell Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 91. TCR2 Therapeutics, Inc. Latest Developments
Table 92. Pfizer Inc. Details, Company Type, T-Cell Therapy Area Served and Its Competitors
Table 93. Pfizer Inc. T-Cell Therapy Product Offered
Table 94. Pfizer Inc. Main Business
Table 95. Pfizer Inc. T-Cell Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 96. Pfizer Inc. Latest Developments
Table 97. DiaCarta, Inc. Details, Company Type, T-Cell Therapy Area Served and Its Competitors
Table 98. DiaCarta, Inc. T-Cell Therapy Product Offered
Table 99. DiaCarta, Inc. Main Business
Table 100. DiaCarta, Inc. T-Cell Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 101. DiaCarta, Inc. Latest Developments
LIST OF FIGURES
Figure 1. T-Cell Therapy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global T-Cell Therapy Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. T-Cell Therapy Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. T-Cell Therapy Sales Market Share by Country/Region (2022)
Figure 8. T-Cell Therapy Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global T-Cell Therapy Market Size Market Share by Type in 2022
Figure 10. T-Cell Therapy in Hospitals
Figure 11. Global T-Cell Therapy Market: Hospitals (2018-2023) & ($ Millions)
Figure 12. T-Cell Therapy in Clinics & Ambulatory Centers
Figure 13. Global T-Cell Therapy Market: Clinics & Ambulatory Centers (2018-2023) & ($ Millions)
Figure 14. T-Cell Therapy in Cancer Research Institutes
Figure 15. Global T-Cell Therapy Market: Cancer Research Institutes (2018-2023) & ($ Millions)
Figure 16. T-Cell Therapy in Others
Figure 17. Global T-Cell Therapy Market: Others (2018-2023) & ($ Millions)
Figure 18. Global T-Cell Therapy Market Size Market Share by Application in 2022
Figure 19. Global T-Cell Therapy Revenue Market Share by Player in 2022
Figure 20. Global T-Cell Therapy Market Size Market Share by Regions (2018-2023)
Figure 21. Americas T-Cell Therapy Market Size 2018-2023 ($ Millions)
Figure 22. APAC T-Cell Therapy Market Size 2018-2023 ($ Millions)
Figure 23. Europe T-Cell Therapy Market Size 2018-2023 ($ Millions)
Figure 24. Middle East & Africa T-Cell Therapy Market Size 2018-2023 ($ Millions)
Figure 25. Americas T-Cell Therapy Value Market Share by Country in 2022
Figure 26. United States T-Cell Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 27. Canada T-Cell Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 28. Mexico T-Cell Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 29. Brazil T-Cell Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 30. APAC T-Cell Therapy Market Size Market Share by Region in 2022
Figure 31. APAC T-Cell Therapy Market Size Market Share by Type in 2022
Figure 32. APAC T-Cell Therapy Market Size Market Share by Application in 2022
Figure 33. China T-Cell Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 34. Japan T-Cell Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 35. Korea T-Cell Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 36. Southeast Asia T-Cell Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 37. India T-Cell Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 38. Australia T-Cell Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 39. Europe T-Cell Therapy Market Size Market Share by Country in 2022
Figure 40. Europe T-Cell Therapy Market Size Market Share by Type (2018-2023)
Figure 41. Europe T-Cell Therapy Market Size Market Share by Application (2018-2023)
Figure 42. Germany T-Cell Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 43. France T-Cell Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 44. UK T-Cell Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 45. Italy T-Cell Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 46. Russia T-Cell Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 47. Middle East & Africa T-Cell Therapy Market Size Market Share by Region (2018-2023)
Figure 48. Middle East & Africa T-Cell Therapy Market Size Market Share by Type (2018-2023)
Figure 49. Middle East & Africa T-Cell Therapy Market Size Market Share by Application (2018-2023)
Figure 50. Egypt T-Cell Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 51. South Africa T-Cell Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 52. Israel T-Cell Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 53. Turkey T-Cell Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 54. GCC Country T-Cell Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 55. Americas T-Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 56. APAC T-Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 57. Europe T-Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 58. Middle East & Africa T-Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 59. United States T-Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 60. Canada T-Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 61. Mexico T-Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 62. Brazil T-Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 63. China T-Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 64. Japan T-Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 65. Korea T-Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 66. Southeast Asia T-Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 67. India T-Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 68. Australia T-Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 69. Germany T-Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 70. France T-Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 71. UK T-Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 72. Italy T-Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 73. Russia T-Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 74. Spain T-Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 75. Egypt T-Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 76. South Africa T-Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 77. Israel T-Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 78. Turkey T-Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 79. GCC Countries T-Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 80. Global T-Cell Therapy Market Size Market Share Forecast by Type (2024-2029)
Figure 81. Global T-Cell Therapy Market Size Market Share Forecast by Application (2024-2029)
Figure 1. T-Cell Therapy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global T-Cell Therapy Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. T-Cell Therapy Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. T-Cell Therapy Sales Market Share by Country/Region (2022)
Figure 8. T-Cell Therapy Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global T-Cell Therapy Market Size Market Share by Type in 2022
Figure 10. T-Cell Therapy in Hospitals
Figure 11. Global T-Cell Therapy Market: Hospitals (2018-2023) & ($ Millions)
Figure 12. T-Cell Therapy in Clinics & Ambulatory Centers
Figure 13. Global T-Cell Therapy Market: Clinics & Ambulatory Centers (2018-2023) & ($ Millions)
Figure 14. T-Cell Therapy in Cancer Research Institutes
Figure 15. Global T-Cell Therapy Market: Cancer Research Institutes (2018-2023) & ($ Millions)
Figure 16. T-Cell Therapy in Others
Figure 17. Global T-Cell Therapy Market: Others (2018-2023) & ($ Millions)
Figure 18. Global T-Cell Therapy Market Size Market Share by Application in 2022
Figure 19. Global T-Cell Therapy Revenue Market Share by Player in 2022
Figure 20. Global T-Cell Therapy Market Size Market Share by Regions (2018-2023)
Figure 21. Americas T-Cell Therapy Market Size 2018-2023 ($ Millions)
Figure 22. APAC T-Cell Therapy Market Size 2018-2023 ($ Millions)
Figure 23. Europe T-Cell Therapy Market Size 2018-2023 ($ Millions)
Figure 24. Middle East & Africa T-Cell Therapy Market Size 2018-2023 ($ Millions)
Figure 25. Americas T-Cell Therapy Value Market Share by Country in 2022
Figure 26. United States T-Cell Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 27. Canada T-Cell Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 28. Mexico T-Cell Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 29. Brazil T-Cell Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 30. APAC T-Cell Therapy Market Size Market Share by Region in 2022
Figure 31. APAC T-Cell Therapy Market Size Market Share by Type in 2022
Figure 32. APAC T-Cell Therapy Market Size Market Share by Application in 2022
Figure 33. China T-Cell Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 34. Japan T-Cell Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 35. Korea T-Cell Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 36. Southeast Asia T-Cell Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 37. India T-Cell Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 38. Australia T-Cell Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 39. Europe T-Cell Therapy Market Size Market Share by Country in 2022
Figure 40. Europe T-Cell Therapy Market Size Market Share by Type (2018-2023)
Figure 41. Europe T-Cell Therapy Market Size Market Share by Application (2018-2023)
Figure 42. Germany T-Cell Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 43. France T-Cell Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 44. UK T-Cell Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 45. Italy T-Cell Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 46. Russia T-Cell Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 47. Middle East & Africa T-Cell Therapy Market Size Market Share by Region (2018-2023)
Figure 48. Middle East & Africa T-Cell Therapy Market Size Market Share by Type (2018-2023)
Figure 49. Middle East & Africa T-Cell Therapy Market Size Market Share by Application (2018-2023)
Figure 50. Egypt T-Cell Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 51. South Africa T-Cell Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 52. Israel T-Cell Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 53. Turkey T-Cell Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 54. GCC Country T-Cell Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 55. Americas T-Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 56. APAC T-Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 57. Europe T-Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 58. Middle East & Africa T-Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 59. United States T-Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 60. Canada T-Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 61. Mexico T-Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 62. Brazil T-Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 63. China T-Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 64. Japan T-Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 65. Korea T-Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 66. Southeast Asia T-Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 67. India T-Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 68. Australia T-Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 69. Germany T-Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 70. France T-Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 71. UK T-Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 72. Italy T-Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 73. Russia T-Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 74. Spain T-Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 75. Egypt T-Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 76. South Africa T-Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 77. Israel T-Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 78. Turkey T-Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 79. GCC Countries T-Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 80. Global T-Cell Therapy Market Size Market Share Forecast by Type (2024-2029)
Figure 81. Global T-Cell Therapy Market Size Market Share Forecast by Application (2024-2029)
